Jaguar Health Inc. surged as investors cheered positive clinical trial progress, and its stocks have been trading up by 34.25 ...

The first global assessment of rare neurological diseases in children finds rising prevalence and disability from 1990 to 2021, declining mortality, and a projected 11.83 percent increase in cases by ...

When the aging brain misfires, the results can be astonishing and a little alarming.

Conscience, a Canadian non-profit dedicated to enabling drug discovery through open science and collaboration for the advancement of accessible treatments, is proud to highlight two recently approved ...

The FDA advised a pre-BLA meeting for ersodetug, a rare disease drug from Handok affiliate Rezolute, despite a missed Phase 3 ...

Rates of enterovirus D68, a respiratory virus that usually causes mild cold-like symptoms in adults but can lead to a rare ...

Researchers from Kennedy Krieger Institute, University of Rochester Medicine and five other institutions released a new ...

Shionogi will acquire IntraBio for $2 billion upfront, adding AQNEURSA for rare neurological diseases. See what the deal means for its portfolio. Read more.

DANCING with the Stars judge Carrie Ann Inaba has spoken out about living with a rare medical condition. While the TV ...

A Palestinian family case series shows four girls with the same homozygous WFS1 mutation developing strikingly different ...

The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.

The family of a 13-year-old boy from Long Beach is asking for help as he remains hospitalized with a rare disease linked to ...